These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 5902055

  • 1. Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.
    Arden GB, Kolb H.
    Br Med J; 1966 Jan 29; 1(5482):270-3. PubMed ID: 5902055
    [No Abstract] [Full Text] [Related]

  • 2. Antimalarial treatment of rheumatoid arthritis.
    Zvaifler NJ.
    Med Clin North Am; 1968 May 29; 52(3):759-64. PubMed ID: 5653948
    [No Abstract] [Full Text] [Related]

  • 3. The EOG in rheumatoid arthritis.
    Pinckers A, Broekhuyse RM.
    Acta Ophthalmol (Copenh); 1983 Oct 29; 61(5):831-7. PubMed ID: 6659891
    [Abstract] [Full Text] [Related]

  • 4. Ocular damage in chloroquine therapy.
    Nylander U.
    Acta Ophthalmol (Copenh); 1967 Oct 29; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Ophthalmic side effects of chloroquine in patients with rheumatoid arthritis].
    Sarmela T, Kajander A.
    Duodecim; 1968 Oct 29; 84(5):306-11. PubMed ID: 5670747
    [No Abstract] [Full Text] [Related]

  • 7. Antimalarials in the treatment of rheumatoid arthritis.
    Zvaifler NJ.
    Mod Treat; 1971 Nov 29; 8(4):769-77. PubMed ID: 4258497
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimalarials as antirheumatic agents and the risk of ocular toxicity.
    Zvaifler NJ.
    GP; 1966 Nov 29; 34(5):128-32. PubMed ID: 5917009
    [No Abstract] [Full Text] [Related]

  • 11. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI.
    J Rheumatol; 1985 Aug 29; 12(4):657-9. PubMed ID: 4057186
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The prevention of drug-induced retinopathies.
    Crews SJ.
    Trans Ophthalmol Soc U K (1962); 1966 Aug 29; 86():63-76. PubMed ID: 5335103
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Ocular changes caused by long-lasting use of chloroquine and its derivatives in rheumatoid disease].
    Drewnowska-Sochańska A, Kuprianowicz W, Petrus B.
    Klin Oczna; 1970 Aug 29; 40(4):499-503. PubMed ID: 5453064
    [No Abstract] [Full Text] [Related]

  • 17. [The changes in the electric retinal activity during resochin treatment].
    Svĕrák J, Peregrin J, Salavec M.
    Klin Monbl Augenheilkd; 1967 Nov 29; 151(5):633-40. PubMed ID: 5597424
    [No Abstract] [Full Text] [Related]

  • 18. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan 29; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 19. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M.
    J Rheumatol; 1999 Sep 29; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract] [Full Text] [Related]

  • 20. On very short wavelength electroretinography. An original technique of diagnosis in infraclinical synthetic antimalarial retinopathies.
    Alfieri R, Sole P.
    Ophthalmologica; 1969 Sep 29; 158 Suppl():661-8. PubMed ID: 5359763
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.